Gulf War Illness Clinical Trials 2023

Gulf War Illness Clinical Trials 2023

Gulf War Illness research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in gulf war illness clinical trials today.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to gulf war illness

What are the top hospitals conducting gulf war illness research?

Across various regions in the United States, distinguished hospitals and research institutions are working vigorously to unravel the complexities surrounding Gulf War Illness (GWI). In Fort Lauderdale, Florida, Nova Southeastern University is making significant strides with two ongoing clinical trials dedicated to understanding GWI. While they may have only recorded their first trial in 2023, their commitment to this area of study is commendable. The Michael E. DeBakey VA Medical Center in Houston stands alongside Nova Southeastern University as a formidable force against GWI with two active trials of its own. Their dedication to improving the lives of veterans affected by this condition is evident through their ongoing efforts since 2023.

Meanwhile, at American University in Washington D.C., researchers are delving into the intricate aspects of GWI through one active trial and continue building upon a foundation set by two previous studies conducted since 2017. Furthermore, Boston University in Massachusetts joins this noble cause with one ongoing trial and an additional study dating back to 2022. Together, these institutions contribute valuable insights into the nature of GWI.

Notably, The University of Alabama at Birmingham has also made notable contributions towards advancing our understanding of GWI by conducting one current clinical trial while having previously undertaken another investigation starting from 2023 onward; their dedication showcases that progress can be achieved regardless if it's just starting out within recent years

These prominent hospitals and esteemed universities serve as beacons of hope for those affected by Gulf War Illness nationwide. By relentlessly pursuing scientific breakthroughs and collaborating on innovative studies related to GWI management and treatment options, each institution plays a vital role in bringing us closer towards improved outcomes for Gulf War veterans suffering from this complex condition

Which are the best cities for gulf war illness clinical trials?

Fort Lauderdale, Florida; Boston, Massachusetts; Houston, Texas; Palo Alto, California; and Washington, District of Columbia are the top cities for gulf war illness clinical trials. These cities each have multiple active trials dedicated to studying various interventions such as dietary intervention groups and N-Acetyl Cysteine (NAC). Additionally, Houston explores the use of recombinant human growth hormone while Palo Alto investigates the efficacy of Active rTMS at the LMC. With a focus on advancing our understanding and treatment options for gulf war illness, these cities offer valuable opportunities for individuals affected by this condition to participate in groundbreaking research.

Which are the top treatments for gulf war illness being explored in clinical trials?

When it comes to exploring potential treatments for Gulf War illness, one therapy stands out as the frontrunner. Recombinant human growth hormone has entered the scene with one active trial dedicated specifically to addressing this condition. This treatment option made its debut in 2023 and is currently being investigated as a possible solution for individuals suffering from Gulf War illness. As research progresses, there is hope that this therapy may bring relief and improve the quality of life for those affected by this complex disorder.

What are the most recent clinical trials for gulf war illness?

Promising advancements are being made in the field of Gulf War illness research, offering hope for those affected by this debilitating condition. One recent clinical trial focused on a dietary intervention group to explore potential benefits for individuals with Gulf War illness. By studying the impact of specific dietary changes, researchers aim to alleviate symptoms and improve quality of life. Additionally, an innovative lactulose breath test has been investigated as a diagnostic tool during Phase 1 trials. These ongoing studies provide valuable insights into understanding and managing Gulf War illness, bringing us closer to effective treatments and support for those who suffer from it.

What gulf war illness clinical trials were recently completed?

Recently, several clinical trials addressing Gulf War Illness have concluded, bringing us closer to understanding and managing this complex condition. Notably, a trial sponsored by the Department of Veterans Affairs was completed in November 2021, investigating potential treatments for Gulf War Illness symptoms. In addition, another study funded by the National Institute on Drug Abuse reached its conclusion in September 2021. These important research endeavors offer hope for individuals affected by Gulf War Illness and highlight ongoing efforts to find effective interventions and support for those who served in the military during that period.